Expression and biosynthetic variation of the epidermal growth factor receptor in human hepatocellular carcinoma-derived cell lines
about
P1343
Systemic therapy of hepatocellular carcinoma: current status and future perspectivesDisplayed correlation between gene expression profiles and submicroscopic alterations in response to cetuximab, gefitinib and EGF in human colon cancer cell lines.Enhanced expression of the protein kinase substrate p36 in human hepatocellular carcinoma.Systemic treatment and targeted therapy in patients with advanced hepatocellular carcinoma.A tyrosine-based signal plays a critical role in the targeting and function of adenovirus RIDalpha proteinStructurally related class I and class II receptor protein tyrosine kinases are down-regulated by the same E3 protein coded for by human group C adenovirusesAdenovirus E3 protein causes constitutively internalized epidermal growth factor receptors to accumulate in a prelysosomal compartment, resulting in enhanced degradationDevelopment of sorafenib and other molecularly targeted agents in hepatocellular carcinoma.RAFT polymerization: an avenue to functional polymeric micelles for drug delivery.Transcription of the human corticotropin-releasing hormone gene in NPLC cells is correlated with Z-DNA formation.Beyond sorafenib: novel targeted therapies for advanced hepatocellular carcinoma.New agents on the horizon in hepatocellular carcinoma.The hepatitis C virus non-structural protein NS5A alters the trafficking profile of the epidermal growth factor receptor.Expression of Rab5a in hepatocellular carcinoma: Possible involvement in epidermal growth factor signaling.Imaging epidermal growth factor receptor phosphorylation in human colorectal cancer cells and human tissues.Phase 2 study of cetuximab in patients with advanced hepatocellular carcinoma.EGF receptor in neoplasia and metastasis.Role of TGF alpha and its receptor in proliferation of immortalized rat tracheal epithelial cells: studies with tyrphostin and TGF alpha antisera.Cytoplasmic juxtamembrane domain of the human EGF receptor is required for basolateral localization in MDCK cells.Adenovirus and protein kinase C have distinct molecular requirements for regulating epidermal growth factor receptor trafficking.Ligand-induced protein tyrosine kinase activity in living cells coexpressing intact EGF receptors and receptors with an extensive cytosolic deletion.Growth-factor independence of a new differentiated hepatitis B virus DNA-negative human hepatoma cell line.EGF stimulates anchorage-independent growth of a human bladder carcinoma cell line (KU1) with an amplified and over-expressed EGF receptor gene.Dimethyl sulphoxide induces a reduced growth rate, altered cell morphology and increased epidermal-growth-factor binding in Hep G2 cells.In vivo distribution of polymeric nanoparticles at the whole-body, tumor, and cellular levels.
P2860
Q26865844-44491384-6F12-46FD-BFE2-92D82A1254C9Q33358967-540D4FFA-D3B4-4811-A627-D228A0126257Q33909691-E3C3E3A8-3CBE-45C9-BBA0-637160CD0A43Q35913461-EBE1912E-1B95-493B-883D-64B18AD11C14Q36099116-143EBF4F-7DE3-4C39-90D9-33D1BC572879Q36233063-2246DD35-6063-48E7-9847-48FBFAA20334Q36654255-EFFC2ADB-8763-443F-9BA4-C696259A95BBQ37015632-C7FDE719-B1D5-425C-A94B-6D95F349036BQ37226523-90D665FC-6BB3-4F27-BBD8-382FE9DEDD12Q37665719-A7993341-4571-4B29-84CE-3F57D41038AFQ37724256-C4114B17-4AA6-46B8-A9A2-6343F8AF08C4Q38074429-E33A2A68-6E71-48C9-8086-001C9728C316Q39973153-2CCB2C3E-9B7A-405D-A644-237B5D1EC786Q40117486-34158E4D-FCAD-478F-8BE1-871064DBCF0CQ40419074-50F71687-E488-40EC-9488-07AB3378149CQ40446595-C673E160-1687-49BE-881B-4EFB61D11B88Q40801239-52F26EAF-0B11-4716-AB6A-977ECBCEBB46Q41185982-7D7D254E-B3B8-4023-A530-1CA84D92531CQ41363735-F5F94D7F-F615-4495-B0FA-FBE972EBBDC3Q41510963-559C6BCC-4330-486E-8BC7-A23F7583D786Q41595580-CA3A3D71-21C4-41FF-9E78-65FCB70EB266Q41733448-035244A9-F25A-4A9D-A2C7-C840EB0FF2FCQ41758031-E0B67915-89E7-437B-A2F2-45B54B0D0C04Q42020224-6F2C8CB6-C7C6-4B7F-95C6-9641AF216577Q53306641-A7F31998-2E6C-47BB-8351-75B6F51A83C3
P2860
Expression and biosynthetic variation of the epidermal growth factor receptor in human hepatocellular carcinoma-derived cell lines
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Expression and biosynthetic va ...... r carcinoma-derived cell lines
@ast
Expression and biosynthetic va ...... r carcinoma-derived cell lines
@en
type
label
Expression and biosynthetic va ...... r carcinoma-derived cell lines
@ast
Expression and biosynthetic va ...... r carcinoma-derived cell lines
@en
prefLabel
Expression and biosynthetic va ...... r carcinoma-derived cell lines
@ast
Expression and biosynthetic va ...... r carcinoma-derived cell lines
@en
P2093
P2860
P356
P1476
Expression and biosynthetic va ...... r carcinoma-derived cell lines
@en
P2093
P2860
P356
10.1128/MCB.8.1.25
P407
P4510
P577
1988-01-01T00:00:00Z